Business · Cumberland
Source-linked news preview · Providence Business News

Neurotech Pharmaceuticals purchased for $550M

Cumberland Published Nov 9, 2026, 11:46 AM

CUMBERLAND – Neurotech Pharmaceuticals Inc., a biotech company creating treatments for therapies for chronic eye diseases, has been acquired by Alcon, a publicly traded eye care company out of Switzerland. Alcon purchased Neurotech for $550 million and may make additional payments contingent on possible commercial achievements, the Rhode Island company announced Oct. 20. Under the […]

Continue at the sourcePublisher: Providence Business News ↗
Read the full story at the publisher's site — we link, we don't republish.
Read at Providence Business News ↗

Last verified Nov 9, 2026, 11:30 PM · Report a correction · Send a tip